AEE
58
-3
O
28
-7
GPC
51
13
UNP
43
-5
DIS
58
-2
ADSK
67
2
WYNN
36
2
LEN
64
3
BF.B
50
-7
DHR
60
4
SCHW
49
4
XYL
58
6
KMI
57
-2
PH
74
3
PFG
59
6
AVGO
49
9
BDX
46
2
MCO
78
3
DOV
69
6
ROP
65
6
AEE
58
-3
O
28
-7
GPC
51
13
UNP
43
-5
DIS
58
-2
ADSK
67
2
WYNN
36
2
LEN
64
3
BF.B
50
-7
DHR
60
4
SCHW
49
4
XYL
58
6
KMI
57
-2
PH
74
3
PFG
59
6
AVGO
49
9
BDX
46
2
MCO
78
3
DOV
69
6
ROP
65
6
Financhill
Back

Neurocrine Biosciences Vs. Bruker Industry Stock Comparison

Sell
41

NBIX
Neurocrine Biosciences

Last Price:
118.32
Seasonality Move:
9.9%
Buy
54

BRKR
Bruker

Last Price:
67.54
Seasonality Move:
6.9%
Sell
41
Neurocrine Biosciences (NBIX) is a Sell

Is Neurocrine Biosciences a Buy, Sell or Hold?

  • The current Neurocrine Biosciences [NBIX] share price is $120.46. The Score for NBIX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • NBIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Bruker (BRKR) is a Buy

Is Bruker a Buy, Sell or Hold?

  • The current Bruker [BRKR] share price is $68.26. The Score for BRKR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BRKR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NBIX Stock Price Chart

What is Neurocrine Biosciences's stock price today?

  • The Neurocrine Biosciences share price today is $120.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight selling pressure.

BRKR Stock Price Chart

What is Bruker's stock price today?

  • The Bruker share price today is $68.26
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRKR is experiencing slight buying pressure.

NBIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.08 Sell
Relative Strength Index (14 RSI): 32.31 Sell
Chaikin Money Flow: -385962 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (118.79 - 145.97) Sell
Bollinger Bands (100): (129.79 - 147.61) Sell

BRKR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.56 Buy
Relative Strength Index (14 RSI): 63.11 Buy
Chaikin Money Flow: 146829 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.57 - 66.25) Buy
Bollinger Bands (100): (61.74 - 71.9) Buy

NBIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 121.13 Sell
20-day SMA: 128.4 Sell
50-day SMA: 139.44 Sell
200-day SMA: 136.34 Sell
8-day EMA: 121.75 Sell
20-day EMA: 127.22 Sell
50-day EMA: 134.41 Sell
200-day EMA: 133.06 Sell

BRKR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.39 Buy
20-day SMA: 65.04 Buy
50-day SMA: 64.44 Buy
200-day SMA: 73.31 Sell
8-day EMA: 65.94 Buy
20-day EMA: 65.16 Buy
50-day EMA: 65.28 Buy
200-day EMA: 69.69 Sell

Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.36 per share, an increase this year of $2.34 per share, and an increase next year of $1.55 per share.

Bruker Earnings Growth & BRKR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.17 per share, an increase this year of $0.06 per share, and an increase next year of $0.47 per share.

Neurocrine Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bruker Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):